Cargando…

Population pharmacokinetics of extended‐release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide

BACKGROUND: Extended‐release levetiracetam (LEV‐XR) has gained acceptance as an antiepileptic drug in dogs. No studies have evaluated its disposition in dogs with epilepsy. HYPOTHESIS/OBJECTIVES: To evaluate the pharmacokinetics of LEV‐XR in epileptic dogs when administered alone or with phenobarbit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñana, Karen R., Otamendi, Arturo J., Nettifee, Julie A., Papich, Mark G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189379/ https://www.ncbi.nlm.nih.gov/pubmed/30238679 http://dx.doi.org/10.1111/jvim.15298

Ejemplares similares

Effect of Chronic Administration of Phenobarbital, or Bromide, on Pharmacokinetics of Levetiracetam in Dogs with Epilepsy
por: Muñana, K.R., et al.
Publicado: (2015)

Incidence of hepatopathies in dogs administered zonisamide orally: A retrospective study of 384 cases
por: Smith, Tess K., et al.
Publicado: (2022)

Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator‐Formulated Itraconazole Capsules and Solution in Healthy Dogs
por: Hasbach, A.E., et al.
Publicado: (2017)

Pharmacokinetics of Single Oral Dose Extended‐Release Levetiracetam in Healthy Cats
por: Barnard, L., et al.
Publicado: (2017)

Evaluation of a collar‐mounted accelerometer for detecting seizure activity in dogs
por: Muñana, Karen R., et al.
Publicado: (2020)

Open‐label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures
por: Cagnotti, Giulia, et al.
Publicado: (2019)

Suspected Phenobarbital‐Induced Pseudolymphoma in a Dog
por: Lampe, R., et al.
Publicado: (2017)

Ampicillin pharmacokinetics in azotemic and healthy dogs
por: Monaghan, Kelly N., et al.
Publicado: (2021)

Clinical characteristics, breed differences, and quality of life in North American dogs with acute steroid‐responsive meningitis‐arteritis
por: Lau, Jeanie, et al.
Publicado: (2019)

Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing
por: Beasley, M.J., et al.
Publicado: (2015)

Presumptive phenobarbital‐induced systemic lupus erythematosus in a domestic dog
por: Phillips, Erin, et al.
Publicado: (2023)

Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats
por: Barnes Heller, Heidi, et al.
Publicado: (2018)

Pharmacokinetics of multivesicular liposomal encapsulated cytarabine when administered subcutaneously in dogs
por: Vazquez Fuster, Irene B., et al.
Publicado: (2020)

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
por: Barr, Ciara A., et al.
Publicado: (2023)

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients
por: Papich, M.G.
Publicado: (2017)

Epileptic seizures triggered by eating in dogs
por: Brocal, Josep, et al.
Publicado: (2020)

The pharmacokinetics of gabapentin in cats
por: Adrian, Derek, et al.
Publicado: (2018)

Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats
por: Smith, Casey, et al.
Publicado: (2019)

Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
por: Roche‐Catholy, Marine, et al.
Publicado: (2022)

Long‐term outcome of epileptic dogs treated with implantable vagus nerve stimulators
por: Harcourt‐Brown, Thomas R., et al.
Publicado: (2023)

Population pharmacokinetic analysis of enrofloxacin and its active metabolite ciprofloxacin after intravenous injection to cats with reduced kidney function
por: Foster, Jonathan D., et al.
Publicado: (2023)

Continuous rate infusion of midazolam as emergent treatment for seizures in dogs
por: Bray, Kathryn Y., et al.
Publicado: (2020)

Parenterally administered vancomycin in 29 dogs and 7 cats (2003‐2017)
por: DeStefano, Ian M., et al.
Publicado: (2018)

Implantable vagus nerve stimulator settings and short‐term adverse effects in epileptic dogs
por: Harcourt‐Brown, Thomas R., et al.
Publicado: (2021)

Clinical Characteristics of Dogs with Progressive Myelomalacia Following Acute Intervertebral Disc Extrusion
por: Castel, A., et al.
Publicado: (2017)

Levetiracetam‐responsive paroxysmal exertional dyskinesia in a Welsh Terrier
por: Green, Sherril, et al.
Publicado: (2021)

Anticoagulant effects of rivaroxaban, prednisone, alone and in combination, in healthy dogs
por: Hafner, Paige M., et al.
Publicado: (2022)

Clinical and Diagnostic Imaging Features of Brain Herniation in Dogs and Cats
por: Lewis, M.J., et al.
Publicado: (2016)

Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts
por: van Straten, Giora, et al.
Publicado: (2019)

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
por: Kuhl, Amanda, et al.
Publicado: (2020)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogs
por: Seo, Do‐Hyun, et al.
Publicado: (2018)

The effect of combined carprofen and omeprazole administration on gastrointestinal permeability and inflammation in dogs
por: Jones, Susan M., et al.
Publicado: (2020)

Cerebrospinal fluid lactate concentrations in dogs with seizure disorders
por: Mariani, Christopher L., et al.
Publicado: (2020)

Presumed pituitary apoplexy in 26 dogs: Clinical findings, treatments, and outcomes
por: Woelfel, Christian W., et al.
Publicado: (2023)

Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders
por: Mariani, Christopher L., et al.
Publicado: (2019)

Vascular endothelial growth factor concentrations in the cerebrospinal fluid of dogs with neoplastic or inflammatory central nervous system disorders
por: Mariani, Christopher L., et al.
Publicado: (2021)

Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs
por: Zwueste, Danielle M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmjkmbhmml954eea1hreqs6eu6